Related by context. All words. (Click for frequent words.) 64 drug eluting stent DES 63 Combo Stent 62 abluminal 62 phase IIa clinical 61 QTinno TM 61 cartilage regeneration 61 CardioFit 60 CRLX# 60 Vascugel 60 ABSORB trial 60 CCX# 60 Novolimus 60 fully bioabsorbable 59 preclinical efficacy 59 coronary stenting 59 mechanical thrombectomy 59 BioMatrix 59 Phase Ib clinical 59 anti restenotic 59 Stabilimax NZ 59 pain palliation 59 DEEP AF 59 QTinno 59 PROMUS Element Stent 59 NAVISTAR R 59 bioresorbable polymer 58 bifurcation stent 58 Eluting Coronary Stent System 58 Myocet 58 Ophena 58 Genous stent 58 BioSTAR ® 58 riociguat 58 MGuard 58 MIST Therapy 58 HepaSphere 58 carotid artery stenting 58 Xanafide 58 MAGE A3 ASCI 58 depsipeptide 58 Aethlon Hemopurifier R 58 SEPET TM 58 CBLC# 58 Microplasmin 58 NEVO ™ 58 AEG# 58 HDL Selective Delipidation 58 Zilver PTX stent 58 HSP# inhibitor 58 pertuzumab 57 fosbretabulin 57 INT# [002] 57 MEND CABG 57 MitraClip device 57 Tryton Side Branch 57 Factor VIIa 57 PFO migraine 57 RE COVER 57 PICSO ® 57 direct thrombin inhibitors 57 bioabsorbable polymer 57 PFO closure 57 AngioJet System 57 BrachySil ™ 57 afamelanotide 57 preclinically 57 Hemospan 57 Endovascular System 57 Degarelix 57 REPEL CV 57 Sirolimus 57 CIPN 57 Liposomal 57 SPIRIT FIRST 57 HuMax EGFr 57 Stent System 57 paclitaxel eluting stent 57 OZURDEX ® 57 HGS# 57 PTNS 57 receptor tyrosine kinase inhibitor 57 vascular disrupting agent 57 paclitaxel eluting stents 57 Cotavance 57 Phase #b/#a clinical 57 TAXUS Element Paclitaxel Eluting 56 Vascugel ® 56 EchoCRT 56 rALLy clinical trial 56 placebo controlled clinical 56 SIR Spheres 56 Spheramine 56 Optical Coherence Tomography 56 herpetic keratitis 56 Balloon Catheter 56 urethral bulking agent 56 BrachySil 56 everolimus eluting stent 56 BioSTAR R 56 plaque excision 56 Traficet EN 56 OZURDEX 56 DXL# 56 Personalized Immunotherapy 56 Kahalalide F 56 phase 2a 56 CytoSorb TM 56 TAXUS TM 56 Aplidin 56 Dual Opioid 56 somatostatin analog 56 Eluting Stent 56 BrachySil TM 56 DAPT 56 Angio Seal Evolution 56 Archexin 56 BAL# [002] 56 STRIDE PD 56 antiangiogenic agent 56 DermTech International 56 functional mitral regurgitation 56 SPIRIT IV 56 EOquin TM 56 Liprostin 56 Coronary Stent System 56 multicenter clinical trials 56 TAXUS Liberte Stent 56 GORE TAG ® 56 TM Drug Eluting 56 CINTREDEKIN BESUDOTOX 56 zotarolimus 56 PRECISE 56 AQ4N 56 davunetide intranasal AL 56 RLY# 56 LCP AtorFen 56 embolic protection device 56 DUROS 56 OHR/AVR# 56 PROMUS Element Everolimus Eluting 56 TRO# 55 liposomal formulation 55 GEM OS2 55 antiplatelet agent 55 tanespimycin 55 Tyrima 55 recurrent GBM 55 Proxinium TM 55 reslizumab 55 Rheos System 55 dermaPACE TM 55 Coronary Stent 55 beta estradiol 55 GORE TAG Device 55 DuraHeart 55 STARFlex R 55 NP2 Enkephalin 55 selective androgen receptor modulator 55 TAXUS Stent 55 deferiprone 55 multicenter clinical 55 GORE VIABAHN Endoprosthesis 55 Phase #/#a 55 QuadraSphere 55 ablation procedures 55 zotarolimus eluting stent 55 cannabinor 55 Onconase 55 Phase IIb clinical trials 55 anti CD3 55 Biolimus A9 55 Phase #b/#a trial 55 Amrubicin 55 biodegradable implant 55 ColonRing 55 Catheter Ablation 55 CA4P 55 Sirolimus eluting Coronary Stent 55 Adhesion Barrier 55 bioresorbable 55 Phase IIIb clinical 55 Epanova 55 isavuconazole 55 Pivotal Trial 55 dose escalation Phase 55 Dalbavancin 55 Zilver PTX 55 orally dosed 55 cardiac resynchronisation therapy 55 HyACT 55 Litx 55 CB2 selective receptor agonist 55 Phase Ib II 55 Symadex 55 MiStent DES 55 BioSTAR TM 55 vorinostat 55 Blinatumomab 55 Randomized Evaluation 55 Annexin V 55 Anavex #-# 55 TissuGlu 55 cediranib 55 NEVO TM 55 peripheral stent 55 VESTAsync 55 Sym# 55 multicenter Phase II 55 paclitaxel poliglumex 55 Telatinib 55 Fleximer 55 Phase IIb III 55 Ventavis 55 PROCHYMAL 55 drug zotarolimus 55 Micromet BiTE 55 drug eluting coronary stents 55 Phase 1b trial 55 Drug Eluting Stents 55 mertansine 55 XIENCE TM 55 Hsp# Inhibitor 55 vidofludimus 55 carotid artery stenting CAS 55 Apoptone 55 teriflunomide 55 Refractory Angina 55 XIENCE V stent 55 intravascular imaging 55 ToGA 55 randomized Phase IIb 55 endothelialization 55 antiplatelet therapies 54 bioabsorbable stent 54 oxybutynin gel 54 OncoVEX GM CSF 54 Dr. Kandzari 54 endovascular therapy 54 Elocalcitol 54 LEUKINE 54 Custom NX 54 Paccocath technology 54 Trofex 54 Percutaneous Tibial Nerve Stimulation 54 assessing T DM1 54 Surgical Sealant 54 Zysolin TM 54 Phase 1b clinical 54 Mobi C 54 ataluren 54 EOquin 54 pharmacokinetic PK study 54 immunotherapeutic vaccine 54 GRNVAC1 54 TG MV 54 oncolytic vaccine 54 anti angiogenic agents 54 XIENCE V Everolimus Eluting 54 MyoCell 54 StemEx R 54 Cardio Vascu Grow 54 cardiac PET scanner 54 Phase 1a clinical 54 PDE4 inhibitor 54 Platinum Chromium 54 CLORETAZINE TM VNP#M 54 ularitide 54 ELACYT 54 BST CarGel R 54 paclitaxel stent 54 CEQ# 54 Polymer Microspheres 54 FFR guided treatment 54 Long Lesion 54 Bivalirudin 54 Polyzene R F 54 refractory prostate cancer 54 TheraSphere R 54 ABSORB 54 vein ablation 54 NEVO 54 antithrombotic 54 Tissue Matrix 54 Inhaled AAT 54 LipiScan 54 Vascular Wrap TM 54 ZACTIMA 54 Phase Ib study 54 Vascular Wrap 54 Phase 1b clinical trials 54 Isolagen Process 54 paclitaxel eluting 54 LibiGel ® 54 CGRP 54 ganaxolone 54 VNP#M 54 Embolic Protection System 54 Novacor R 54 romidepsin 54 APTIVUS 54 mm Stent 54 refractory angina 54 Neovasc Reducer 54 phase IIb clinical 54 FVIIa 54 relapsing multiple sclerosis 54 carotid stenting procedures 54 Pivotal Clinical Trial 54 JenaValve 54 trastuzumab DM1 T DM1 54 plasma kallikrein inhibitor 54 replacement PAVR 54 MGuard ™ 54 endoluminal 54 PD2i ® nonlinear algorithm 54 Stabilimax 54 PD2i 54 cangrelor 54 Elagolix 54 HeartNet 54 CCX# B 54 cinacalcet 54 TM Everolimus Eluting 54 HuMax CD#b 54 acyclovir Lauriad R 54 Electronic Brachytherapy 54 Carotid 54 EDEMA3 54 MGuard TM 54 Capesaris 54 Bucindolol 54 recurrent glioma 54 Zingo TM 54 multicenter prospective 54 bevacizumab Avastin ® 54 interventional therapies 54 Destination Therapy 54 iodixanol 54 iliac artery disease 54 LVAS 54 Lixivaptan 54 ClosureFAST 54 sipuleucel T 54 phase Ib 54 VESTASYNC 54 InterStim Therapy 54 Pimavanserin 54 AMD# [003] 54 PROLARIS 54 ADAGIO study 54 Surgical Ablation System 54 platinum chromium alloy 54 myoblast therapy 54 drug eluting coronary stent 54 TAXUS ATLAS 53 Yondelis ® 53 Coherex FlatStent 53 Cx# [002] 53 Calmare Therapy Treatment 53 antiarrhythmic drug 53 sulodexide 53 YONDELIS 53 octreotide implant 53 balloon kyphoplasty procedure 53 Tesetaxel 53 NCCTG 53 catheter occlusion 53 Cooled ThermoTherapy 53 APEX PD 53 PSMA ADC 53 Exelixis compounds 53 ClosureFAST catheter 53 TAXUS V 53 trabectedin 53 VersaFilm 53 novel oral anticoagulant 53 Cannabinor 53 external counterpulsation systems 53 coronary stent merged 53 mTOR inhibitor 53 NAVISTAR ® THERMOCOOL ® 53 REG1 53 platelet inhibitor 53 bifurcation lesions 53 Optical Biopsy System 53 cardiac PET 53 Phase 2b study 53 Plasmin 53 EverFlex 53 Edwards SAPIEN valve 53 Afatinib 53 STENTYS 53 Phase IIB 53 HDACi 53 phase IIb trial 53 Fibrin Pad 53 Phase IIB clinical 53 DU #b 53 CCR5 antagonist 53 Cell Pouch System 53 renal artery stenting 53 recombinant tissue plasminogen 53 Acute Myocardial Infarction AMI 53 multimodality imaging 53 Zemplar Capsules 53 BRAF inhibitor 53 TAXUS Liberte 53 antiangiogenic therapy 53 GEM OS1 53 Phase IIIb 53 ZYBRESTAT fosbretabulin 53 CRMD# 53 Cand5 53 carotid stents 53 Ophena TM 53 adjuvant radiotherapy 53 Orqis Medical 53 StarClose 53 drug eluting stents 53 Heparin Bioactive Surface 53 somatostatin analogue 53 ClearPath HDR 53 RELIANT Trial 53 Hexvix 53 selective antagonist 53 BST CarGel 53 #beta estradiol 53 rhBMP 2 53 multicenter randomized Phase 53 ThermoDox ® 53 acute coronary syndromes ACS 53 EP #R 53 Phase 2a trial 53 Phase IIa trials 53 CYPHER Stent 53 TactiCath 53 carotid stenting 53 everolimus eluting stents 53 liposomal doxorubicin 53 Endeavor drug eluting 53 Ketotransdel 53 TQT 53 Mipomersen 53 TUMT 53 liver resection 53 Pradefovir 53 Tarceva TM 53 dermaPACE 53 metaglidasen 53 MoxDuo 53 Thorough QT 53 IN.PACT Falcon 53 proteasome inhibitor bortezomib 53 trodusquemine 53 orally administered inhibitor 53 antiplatelet therapy 53 CYPHER ® 53 budesonide foam 53 ART# 53 bi ventricular pacing 53 Eurocor 53 ThermoDox 53 TAXUS ® 53 hypoxia activated prodrug 53 ThermoDox R 53 VisuMax 53 Sublative Rejuvenation 53 elacytarabine 53 ReValving System 53 WX UK1 53 Retisert 53 PSN# [002] 53 TARIS 53 Nitinol Stent 53 CYPHER R Sirolimus eluting 53 HAp 53 peripheral vascular stent 53 ximelagatran 53 OMNARIS HFA 53 Stent Thrombosis 53 GLP toxicology studies 53 pharmacokinetic characteristics 53 topically administered 53 UPLYSO 53 drug eluting stent 53 Biliary System 53 CINQUIL 53 ADP receptor antagonist 53 Glufosfamide 53 Aryplase 53 cathepsin K inhibitor 53 AZILECT ® 53 TOLAMBA 53 TAXUS stent 53 RhuDex 53 randomized multicenter trial 53 sunitinib malate 53 Nanocort 53 Demineralized Bone Matrix 53 Activated Collagen 53 Pipeline Embolization Device 53 carotid artery stent 53 SYN# 53 acetonide FA 53 Percutaneous Transluminal Coronary Angioplasty 53 percutaneous aortic valve 53 Phase #b/#a 53 CorPath 53 percutaneous interventions 53 cardiac resynchronization 53 GP IIb IIIa inhibitors 53 VALSTAR 53 rt PA 53 COR Analyzer 53 Endeavor stent 53 Mitral Contour System 53 microwave hyperthermia 53 Macroplastique 53 Transdrug ® nanoparticle 53 neratinib 52 OLYMPIA registry 52 fenretinide 52 LT NS# 52 pulsed electromagnetic field 52 MGN# 52 TAXUS VI 52 OncoGel 52 pharmacodynamic profile 52 Catheter ablation 52 Akt inhibitor 52 OvaRex ® MAb 52 OmniWave 52 Irinotecan 52 GRN# 52 Emboshield 52 PolyTouch 52 AngioJet 52 Levacor 52 IV Busulfex 52 Delafloxacin 52 dose escalation clinical 52 Atom Stent 52 Luveniq 52 Gliadel Wafer 52 Elekta Infinity 52 ENDEAVOR II 52 multicentre randomized 52 EECP R 52 regorafenib 52 ATL/TV# 52 Fondaparinux 52 TAXUS Express2 Paclitaxel Eluting 52 Reconstructive Tissue Matrix 52 PROMUS 52 Trevo System 52 cobalt chromium 52 stent restenosis 52 CYPHER ® Sirolimus eluting 52 trastuzumab Herceptin ® 52 R#/MEM # 52 ADVANCE PD 52 PREOS R 52 sidebranch 52 phase IIIb 52 Temsirolimus 52 volociximab 52 multicenter randomized clinical 52 II Clinical Trial 52 metastatic renal cell carcinoma 52 TAXUS IV 52 Endoscopic Ablation System 52 Aflibercept 52 laser atherectomy 52 Crystalens AO 52 Hyphanox 52 Aposense 52 stated Michelle Berrey 52 Embolic Protection Device 52 Lauriad 52 Gabapentin GR 52 stent coating 52 Phase Ib clinical trials 52 MRgFUS 52 OSMOPREP 52 bioabsorbable stents 52 Fully Covered Stent 52 RELIANT trial 52 beta 1a 52 SUTENT ® 52 XP #L 52 Probuphine 52 clot retrieval 52 sorafenib Nexavar 52 PROSTASCINT R 52 HIF PH inhibitors 52 Sirolimus eluting 52 CUSTOM III 52 CHARISMA trial 52 Endurant 52 Cellulaze 52 convenient dosing regimens 52 Diamondback #deg 52 selective orally bioavailable 52 orthoPACE 52 AFRS TM 52 Toraymyxin TM 52 unstable angina UA 52 PROMUS Element 52 Drug Eluting Stent 52 TREDAPTIVE 52 patients undergoing CABG 52 MaxCyte STX 52 Doxil ® 52 prospective multicenter 52 humanized monoclonal 52 vapreotide acetate 52 favorable pharmacokinetic profile 52 CYPHER stent 52 Ranibizumab 52 Drug Eluting 52 PTH analogue 52 pivotal bioequivalence 52 phase IIa 52 TAXUS Express Stent 52 SUPERA stent 52 oral antiplatelet therapy 52 OMP #M# 52 Resten MP 52 Zoraxel 52 ReValving 52 EASE Trial 52 Valdoxan 52 Acute Myocardial Infarction 52 chemoembolization 52 NOX E# 52 MYDICAR 52 mycophenolate mofetil 52 ONCONASE R 52 XIENCE V PROMUS Stent 52 INFUSE Bone Graft 52 oral treprostinil 52 osteobiologic 52 omega interferon 52 Factor Xa inhibitors 52 relapsed ovarian cancer 52 multicenter trials 52 Altrazeal TM 52 sirolimus stent 52 subcutaneously administered 52 Tacrolimus 52 electrosurgical generator 52 Delcath PHP System 52 MyoCell SDF 1 52 Bare Metal Stent 52 Liberte TM 52 amrubicin 52 alvespimycin 52 registrational Phase 52 lapatinib Tykerb 52 ® Perfexion 52 BAY #-# 52 ALSYMPCA 52 ARIKACE 52 Phase IIIb study 52 Ranolazine 52 XIENCE PRIME 52 interferon beta therapy 52 oral rivaroxaban 52 VITAL Trial 52 CardioPass TM 52 STENT 52 sirolimus eluting stents 52 lucinactant 52 juvenile chondrocytes 52 visit www.dobimedical.com 52 vascular interventional 52 BRIM2 52 transesophageal 52 antithrombotic therapies 52 IAP inhibitor 52 Tavocept 52 ORMD 52 Phase III confirmatory 52 Cypher Sirolimus 52 Rainbow SET 52 HALO# [002] 52 carotid stent 52 randomized controlled Phase 52 Neoadjuvant 52 CAPHOSOL R 52 Initiated Phase 52 StemEx 52 PEGylated interferon 52 OvaDx 52 Phase IIA 52 CryoMaze 52 GAMMAGARD 52 AIGISRx 52 MarginProbe 52 metastatic hormone refractory 52 Pivotal Phase II 52 APEX AMI trial 52 Simulect 52 Augment Injectable 52 ARIXTRA 52 TOCOSOL Paclitaxel 52 CCR9 antagonist 52 SYNERGY Stent 52 accommodating IOL 51 murine monoclonal antibody 51 Ablation System 51 Nanobody 51 MacuSight 51 drug eluting balloon 51 Iluvien ® 51 bronchial thermoplasty 51 Trifecta valve 51 GW# [003] 51 glucokinase activator 51 Aneurysm Repair 51 Coronary Artery Bypass Graft 51 Endeavor DES 51 Bosutinib 51 Carticel 51 TheraCIM 51 FluoroPharma 51 RE MODEL 51 oral ridaforolimus 51 Endoscopic ultrasound 51 SilverHawk 51 Artelon ® 51 Benign Prostatic Hyperplasia BPH 51 Plenaxis TM 51 TBC# 51 Cypher Stent 51 MIST II 51 GORE VIABAHN ® 51 Imprime PGG 51 Feasibility Trial 51 concurrent chemoradiation 51 pharmacodynamic PD 51 Vernakalant 51 ganetespib 51 Phase Ib 51 Val HeFT 51 solithromycin 51 GlucoLight 51 pharmacokinetic PK 51 Cloretazine ® 51 Cardio3KG 51 IntuiTrak 51 Onalta ™ 51 NeuroFlo 51 EndoTAG TM -1 51 Evicel 51 dacetuzumab 51 Hepatitis C Virus HCV 51 VBLOC TM 51 REVEAL Registry 51 ZYBRESTAT 51 Vaxfectin R adjuvant 51 SUPERA 51 phase III ACCLAIM 51 Urocidin 51 Exherin TM 51 docetaxel Taxotere ® 51 Enable valve 51 CTO recanalization 51 TAXUS Express Atom Stent 51 CIMZIA ™ 51 Dacogen decitabine 51 Myotech CSS 51 antiarrhythmic 51 platinum chromium PROMUS 51 Protelos 51 laser photocoagulation 51 HCV protease inhibitors 51 SpyGlass System 51 IIa trials 51 analgesic efficacy 51 eluting stent 51 Microwave Ablation System 51 MYDICAR ® 51 phase IIb study 51 InspireMD 51 Bone Graft 51 antiarrhythmic drugs 51 Valsartan 51 FFR measurement 51 vProtect TM Luminal Shield 51 minimally invasive technique 51 miRview mets 51 Phase 2a 51 MEND CABG II 51 KRN# 51 Surgical Mesh 51 chemoradiotherapy 51 chimeric monoclonal antibody 51 Tarmogen 51 edoxaban 51 WavSTAT 51 Acute Ischemic Stroke 51 Miracor 51 Luteinizing Hormone Releasing Hormone 51 Ascendra 51 Cloretazine 51 bioabsorbable 51 TAXUS R 51 carotid endarterectomy CEA 51 Phase III pivotal 51 ePTFE graft 51 Phase III HEAT 51 Zirgan 51 IN.PACT 51 RenalGuard Therapy 51 neointimal 51 radiolabeled 51 SANVAR 51 CytoFabTM 51 multicenter phase 51 ALTROPANE 51 oral anticoagulants 51 plerixafor 51 MitraClip R 51 icatibant 51 coronary intervention 51 Targretin 51 Chemophase 51 MADIT II 51 R Paclitaxel Eluting 51 Anastomosis 51 OncoVex 51 GRAVITAS trial 51 Vascular Closure Device 51 LMWH 51 phase IIb 51 XIENCE 51 Delcath Phase III 51 Abbott bioabsorbable stent 51 Solesta 51 Lenalidomide 51 Alequel 51 placebo controlled Phase 51 PresbyLens ® 51 vernakalant hydrochloride 51 Smartlipo MPX 51 CD HORIZON 51 endovascular procedures 51 standard chemotherapy regimen 51 WATCHMAN device 51 DispersinB R 51 AngioSculpt 51 multicenter randomized controlled 51 self expanding nitinol 51 Angiocept 51 modulators SERMs 51 CardioPET 51 axitinib 51 Anti Bacterial Envelope 51 LB# [003] 51 Retisert TM 51 Revimmune 51 surgical ablation 51 steroid refractory 51 Devax 51 Alfimeprase 51 antithrombotic therapy 51 stent DES 51 PERSEUS 51 Endologix Powerlink System 51 Intravail R 51 DuraHeart TM 51 BEMA TM Fentanyl 51 Restenosis 51 Phase 2b trial 51 Ozurdex 51 DB# [003] 51 Neuradiab 51 bioabsorbable drug eluting 51 Abciximab 51 Cleviprex TM clevidipine 51 randomized controlled clinical 51 Pharmacokinetic studies 51 Tomophase 51 RE LY ® 51 miRview meso 51 endothelial keratoplasty 51 Orazol 51 Angiox R 51 Sideguard 51 relapsing remitting MS RRMS 51 pro angiogenic 51 cortical stimulation 51 Intervention Effectiveness 51 Bendavia 51 ASSERT trial 51 sirolimus eluting stent 51 rhThrombin 51 PREOS 51 AGGRASTAT ® 51 Arikace 51 Teysuno 51 Ereska 51 mapatumumab 51 multicenter Phase 51 Prodarsan 51 OsteoSponge ® SC 51 cetuximab Erbitux ® 51 BCG refractory carcinoma 51 Powerlink System 51 TAXUS Liberté stent 51 RECOTHROM R 51 protein kinase inhibitors 51 cardiac perfusion 51 fallopian tube cancers 51 Dynesys 51 EXPLORE Xa 51 Atu# 51 Estracure 51 NeoDisc 51 arterial thrombosis 51 PEAK PlasmaBlade 51 bioresorbable stent 51 ibandronate 50 cerebral oximetry 50 CG# [003] 50 MKC# MKC# PP 50 diagnostic modality 50 NurOwn 50 DCVax ® Brain 50 FORE SIGHT 50 Jetstream G2 50 rALLy 50 BioMatrix TM 50 glycoprotein GP IIb IIIa 50 AEGR 50 ACUROX ® 50 Transdel TM 50 fibrinolytic 50 Intravitreal 50 Phase IIa trial 50 Angiographic 50 LHRH agonist 50 strontium ranelate 50 GeneICE 50 TAXUS Liberte stent 50 Amphinex ® 50 thrombolytics 50 FASLODEX 50 Augment Injectable Bone Graft 50 Aloxi R 50 LightTouch 50 Thrombin 50 Cinacalcet HCl 50 PrevOnco 50 ELIQUIS 50 Endeavor Drug Eluting 50 Dabigatran etexilate 50 Curaxin CBLC# 50 Phase III psoriasis 50 Brinavess 50 MagniFuse 50 MicroPulse 50 Fenretinide 50 Cordis Cypher 50 eprotirome 50 defibrillator CRT D 50 Endosense TactiCath 50 TELCYTA 50 Sanvar R 50 LCP Tacro 50 SANUWAVE 50 subcutaneous immunoglobulin 50 CryoSeal FS System 50 pegylated liposomal doxorubicin 50 Plicator 50 Provacel 50 Quinamed 50 Laser Lok 50 Diabetic Macular Edema 50 olaparib 50 Civacir 50 VBLOC Therapy 50 PressureWire 50 refractory CLL 50 Novo TTF 50 DDW 50 cytoreductive surgery 50 randomized discontinuation 50 Paradigm Spine 50 nanoviricide 50 TriActiv R 50 dosage regimens 50 Heartmate 50 ablation therapy 50 HeartMate ® 50 ATS CryoMaze TM 50 intravenous dosing 50 ACTIVE W